EMN
Eastman Chemical Co
$
59.640
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
61.770
Open
61.770
VWAP
59.82
Vol
2.49M
Mkt Cap
6.80B
Low
59.380
Amount
149.12M
EV/EBITDA(TTM)
6.93
Total Shares
117.60M
EV
11.63B
EV/OCF(TTM)
11.53
P/S(TTM)
0.79
Eastman Chemical Company is a global specialty materials company that produces a range of products found in items people use every day. Its segments include Advanced Materials (AM), Additives & Functional Products (AFP), Chemical Intermediates (CI), and Fibers. The AM segment produces and markets polymers, films, and plastics with differentiated performance properties for value-added end-uses in transportation; durables and electronics; building and construction; medical and pharma, and consumables end-markets. AFP segment manufactures materials for products in food, feed, and agriculture; transportation; water treatment and energy; personal care and wellness; building and construction; consumables, and durables and electronics end-markets. The CI segment sells intermediates for end-markets, such as industrial chemicals and processing, building and construction, health and wellness, and food and feed. Its Fibers segment manufactures and sells acetate tow and triacetin plasticizers.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q2
FY2026Q1
FY2025Q4
2.28B
-0.16%
1.762
+10.11%
2.20B
-4.02%
1.390
-27.22%
2.05B
-8.54%
0.916
-50.99%
Estimates Revision
The market is revising Downward the revenue expectations for Eastman Chemical Company (EMN) for FY2025, with the revenue forecasts being adjusted by -0.54% over the past three months. During the same period, the stock price has changed by -2.10%.
Revenue Estimates for FY2025
Revise Downward
-0.54%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-4.46%
In Past 3 Month
Stock Price
Go Down
-2.10%
In Past 3 Month
12 Analyst Rating
Wall Street analysts forecast EMN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EMN is 72.92 USD with a low forecast of 60.00 USD and a high forecast of 80.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Buy
3 Hold
0 Sell
Strong Buy
Current: 59.640
Low
60.00
Averages
72.92
High
80.00
Current: 59.640
Low
60.00
Averages
72.92
High
80.00
UBS
Buy
downgrade
$75 -> $73
2025-11-05
New
Reason
UBS
Price Target
$75 -> $73
2025-11-05
New
downgrade
Buy
Reason
UBS lowered the firm's price target on Eastman Chemical to $73 from $75 and keeps a Buy rating on the shares. Eastman Chemical is maintaining "solid" free cash flow through the earnings trough, the analyst tells investors in a research note.
BofA
Buy
maintain
$74 -> $75
2025-11-05
New
Reason
BofA
Price Target
$74 -> $75
2025-11-05
New
maintain
Buy
Reason
BofA raised the firm's price target on Eastman Chemical to $75 from $74 and keeps a Buy rating on the shares. 2026 earnings tailwinds such as cost savings and an asset utilization ramp are material enough to lead to earnings improvement from 2025, even if end-market demand remains sluggish and the company continues to focus on cash generation at the expense of profits, the analyst tells investors.
RBC Capital
Outperform
maintain
$74 -> $71
2025-10-14
Reason
RBC Capital
Price Target
$74 -> $71
2025-10-14
maintain
Outperform
Reason
RBC Capital lowered the firm's price target on Eastman Chemical to $71 from $74 and keeps an Outperform rating on the shares as part of a broader research note previewing Q3 results for Chemicals companies. Recent conversations with the industry's Investor Relations teams have generally indicated that demand has remained somewhat tepid through Q3, the analyst tells investors in a research note. Building and Construction activity has been somewhat muted, and while rate cuts could help, a weak job market remains a headwind to new home starts and existing turnover, RBC added. Demand for consumer durables also has yet to see a material recovery, the firm states.
Wells Fargo
Overweight
maintain
$70 -> $80
2025-09-16
Reason
Wells Fargo
Price Target
$70 -> $80
2025-09-16
maintain
Overweight
Reason
Wells Fargo raised the firm's price target on Eastman Chemical to $80 from $70 and keeps an Overweight rating on the shares despite cutting outlook. The firm says Eastman has leverage to interest rate cuts, about 50% of sales and could see a strong earnings recovery.
Wells Fargo
Overweight
downgrade
$90 -> $70
2025-08-04
Reason
Wells Fargo
Price Target
$90 -> $70
2025-08-04
downgrade
Overweight
Reason
Wells Fargo lowered the firm's price target on Eastman Chemical to $70 from $90 and keeps an Overweight rating on the shares. The firm recognizes its positive view was derailed by weaker than expected demand but believes its base earnings power is much higher than the second half of 2025 trough.
Citi
Buy
downgrade
$90 -> $68
2025-08-04
Reason
Citi
Price Target
$90 -> $68
2025-08-04
downgrade
Buy
Reason
Citi lowered the firm's price target on Eastman Chemical to $68 from $90 and keeps a Buy rating on the shares. The firm cut estimates post the company's Q2 report and outlook but believes the share selloff is likely overdone.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Eastman Chemical Co (EMN.N) is 10.32, compared to its 5-year average forward P/E of 11.81. For a more detailed relative valuation and DCF analysis to assess Eastman Chemical Co 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Undervalued
5Y Average PE
11.81
Current PE
10.32
Overvalued PE
13.10
Undervalued PE
10.51
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
8.80
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
9.55
Undervalued EV/EBITDA
8.04
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
1.54
Current PS
61.09
Overvalued PS
6.01
Undervalued PS
-2.92
Financials
Annual
Quarterly
FY2025Q3
YoY :
-10.63%
2.20B
Total Revenue
FY2025Q3
YoY :
-40.95%
212.00M
Operating Profit
FY2025Q3
YoY :
-74.03%
47.00M
Net Income after Tax
FY2025Q3
YoY :
-73.20%
0.41
EPS - Diluted
FY2025Q3
YoY :
-3.99%
265.00M
Free Cash Flow
FY2025Q3
YoY :
-19.55%
19.75
Gross Profit Margin - %
FY2025Q3
YoY :
-32.20%
4.38
FCF Margin - %
FY2025Q3
YoY :
-71.02%
2.13
Net Margin - %
FY2025Q3
YoY :
-17.03%
8.04
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
4.8M
USD
4
Bought
0-3
0
0.0
USD
Months
3-6
7
1.4M
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 626.44% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
20.6K
Volume
2
0-12
Months
21.9K
Volume
4
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
2
60.7K
Volume
Months
0-12
2
8.4K
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
8.0K
USD
1
6-9
Months
16.0K
USD
2
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
2
16.0K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
4.8M
USD
4
Bought
0-3
0
0.0
USD
Months
3-6
7
1.4M
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
EMN News & Events
Events Timeline
2025-11-04 (ET)
2025-11-04
04:55:00
Qnity Electronics Set to Take Eastman Chemical's Place in S&P 500 Starting November 4th
2025-11-03 (ET)
2025-11-03
16:41:36
Eastman Chemical projects FY25 EPS between $5.40 and $5.65, below consensus of $5.77
2025-11-03
16:40:46
Eastman Chemical announces Q3 EPS of $1.14, falling short of consensus estimate of $1.17
Sign Up For More Events
Sign Up For More Events
News
9.5
11-04NASDAQ.COMPinnedEastman Chemical Reports Decline in Q3 Earnings
6.0
11-05BenzingaUBS Reiterates Buy Rating for Eastman Chemical, Adjusts Price Target to $73
6.0
11-05BenzingaWells Fargo Keeps Overweight Rating on Eastman Chemical, Reduces Price Target to $70
Sign Up For More News
People Also Watch
FND
Floor & Decor Holdings Inc
58.860
USD
-4.20%
TLN
Talen Energy Corp
385.930
USD
-4.35%
PCVX
Vaxcyte Inc
41.710
USD
+3.45%
EVR
Evercore Inc
302.870
USD
-0.20%
FOX
Fox Corp
59.340
USD
+1.68%
SEIC
SEI Investments Co
82.190
USD
-0.23%
TAP
Molson Coors Beverage Co
44.090
USD
-2.41%
ONTO
Onto Innovation Inc
131.750
USD
-2.95%
PAG
Penske Automotive Group Inc
154.860
USD
-1.84%
NLY
Annaly Capital Management Inc
21.610
USD
-0.41%
FAQ
What is Eastman Chemical Co (EMN) stock price today?
The current price of EMN is 59.64 USD — it has decreased -2.37 % in the last trading day.
What is Eastman Chemical Co (EMN)'s business?
What is the price predicton of EMN Stock?
What is Eastman Chemical Co (EMN)'s revenue for the last quarter?
What is Eastman Chemical Co (EMN)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Eastman Chemical Co (EMN)'s fundamentals?
How many employees does Eastman Chemical Co (EMN). have?